Join
Live feed
·
INSIDERFilingvia Quantisnow
Eagle Pharmaceuticals Inc. logo

SEC Form 4: David Pernock disposed of $90,248 worth of Common Stock (1,892 units at $47.70), decreasing ownership by 4% to 44,925 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EGRX (Eagle Pharmaceuticals Inc.) and more on Quantisnow.